EUVIMEDOpdag EUVIMED
MetaanalyseOpen access · CC BY-NC-ND 4.0

Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials

Daniela K van Santen iD, Sara Lodi, Paul Dietze, Wijnand van den Boom, Kanna Hayashi iD, Huiru Dong, Zishan Cui, Lisa Maher iD, Matthew Hickman iD, Anders Boyd, Maria Prins

Addiction · 2023-06 · 118 (6) · 1116-1126

DOI: 10.1111/add.16147 ↗

At a glance

Metaanalyse in Addiction, 2023-06. Written by Daniela K van Santen and 10 co-authors. Institution: Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, The Netherlands. Major MEDLINE topics: Substance Abuse, Intravenous, Drug Users, Hepatitis C, HIV Infections. Cited 27 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Medical Research Council, NIDA NIH HHS, NIAID NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims Although the Netherlands, Canada and Australia were early adopters of harm reduction for people who inject drugs (PWID), their respective HIV and hepatitis C (HCV) epidemics differ. We measured the pooled effect of needle and syringe program (NSP) and opioid agonist therapy (OAT) participation on HIV and HCV incidence in these settings.

Design

For each cohort, we emulated the design and statistical analysis of a target trial using observational data. Setting and Participants We included PWID at risk of HIV or HCV infection from the Amsterdam Cohort Studies (1985–2013), Vancouver Injection Drug Users Study (1997–2009) and Melbourne Injecting Drug User Cohort Study (SuperMIX) (2010–2021).

Measurements

Separately for each infection and cohort (only HCV in SuperMIX), marginal structural models were used to compare the effect of comprehensive (on OAT and 100% NSP coverage or on OAT only if no recent injection drug use) versus no/partial NSP/OAT (no OAT and/or

Subjects

MeSH terms (MEDLINE)

Substance Abuse, IntravenousDrug UsersHepatitis CHIV InfectionsHumansHepacivirusNeedle-Exchange ProgramsAnalgesics, OpioidCohort Studies

Author keywords

Emulated trialHIVharm reduction programshepatitis C virusneedle and syringe programsopioid agonist therapypeople who inject drugs

Substances

Analgesics, Opioid

Authors and institutions

  • Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
  • Department of Disease Elimination, Burnet Institute, Melbourne, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
  • British Columbia Centre on Substance Use, Vancouver, Canada.
  • Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.

ORCID profiles: Daniela K van Santen, Kanna Hayashi, Lisa Maher, Matthew Hickman

Funding

  • Medical Research Council
  • NIDA NIH HHS
  • NIAID NIH HHS

Cite

APA

van Santen, D. K., Lodi, S., Dietze, P., van den Boom, W., Hayashi, K., Dong, H., Cui, Z., Maher, L., Hickman, M., Boyd, A., & Prins, M. (2023). Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials. Addiction. https://doi.org/10.1111/add.16147

Vancouver

van Santen DK, Lodi S, Dietze P, van den Boom W, Hayashi K, Dong H, et al. Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials. Addiction. 2023. doi:10.1111/add.16147

BibTeX
@article{vanSanten2023,
  author = {van Santen, Daniela K and Lodi, Sara and Dietze, Paul and van den Boom, Wijnand and Hayashi, Kanna and Dong, Huiru and Cui, Zishan and Maher, Lisa and Hickman, Matthew and Boyd, Anders and Prins, Maria},
  title = {Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials},
  journal = {Addiction},
  year = {2023},
  doi = {10.1111/add.16147}
}
Start for free →